CAR T-Cell Therapy in Metastatic CRPC and Future Directions in Care
August 29th 2023Closing out their final module, expert panelists consider the role of CAR T-cell therapy in metastatic castration-resistant prostate cancer and look toward future evolutions in the broader treatment landscape.
Read More